News
Get in Touch
Our Locations
Q² Solutions, an IQVIA and Quest Diagnostics Joint Venture, Collaborates with University of Texas Medical Branch to Help Accelerate Development of COVID-19 Vaccines
MORRISVILLE, N.C. – MARCH 24, 2020 – Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its...Q² Solutions Expands Vaccines Business Development Coverage in Europe
Morrisville, N.C. – February 12, 2020 – Q2 Solutions, a leading clinical trial laboratory services organization, is pleased to announce the addition of business development resources in support of...Q² Solutions Expands Capabilities in Singapore
Morrisville, N.C. – December 13, 2019 – Q2 Solutions, a leading clinical trial laboratory services organization, proudly announces the relocation and expansion of its clinical trial testing...Q² Solutions to Expand Genomics Capabilities and Form a Translational Sciences and Innovation Laboratory, Creating 750 New Jobs in North Carolina over the next 10 years
Morrisville, N.C. – November 27, 2019 – Q2 Solutions, a leading clinical trial laboratory services organization, in collaboration with the North Carolina Department of Commerce and the Economic...Q² Solutions Welcomes Dr. Bob Bailer as Head of Vaccines Business Unit
Morrisville, N.C. – August 19, 2019 – Q2 Solutions, a leading clinical trial laboratory services organization, announced today the addition of Dr. Bob Bailer as Head of the Vaccines Business Unit.As...Q² Solutions, HSBlox and R3 announce successful Proof-of-Concept of blockchain-based solution
Tracking of Human Biological Samples in Clinical ResearchQ² Solutions Announces Deployment of Next Generation Flow Cytometry Services
Q2 Solutions Globally Deploys 30+ Color Flow Cytometry CapabilityQ² Solutions | EA Genomics launches Illumina’s TruSight™ Oncology 500 Tumor Profiling assay services for the analysis of Tumor Mutational Burden
Morrisville, N.C. – April 8, 2019 – Q2 Solutions | EA Genomics launches Illumina’s TruSight™ Oncology 500 (TSO 500) next-generation sequencing (NGS) assay services for the analysis of key...